View in EDS

RITONAVIR-BASED ANTI-RETROVIRAL THERAPY IS ASSOCIATED WITH A LOWER EJECTION FRACTION AND AN INCREASED RISK FOR DECOMPENSATED HEART FAILURE AND CARDIOVASCULAR MORTALITY AMONG PERSONS LIVING WITH HIV.

Saved in:
Bibliographic Details
Title: RITONAVIR-BASED ANTI-RETROVIRAL THERAPY IS ASSOCIATED WITH A LOWER EJECTION FRACTION AND AN INCREASED RISK FOR DECOMPENSATED HEART FAILURE AND CARDIOVASCULAR MORTALITY AMONG PERSONS LIVING WITH HIV.
Authors: Alvi, Raza M.1, Neilan, Anne M.1, Tariq, Noor1, Awadalla, Magid1, Banerji, Dahlia1, Rokicki, Adam1, Triant, Virginia1, Zanni, Markella V.1, Neilan, Tomas1
Source: Journal of the American College of Cardiology (JACC). Mar2018 Supplement, Vol. 71, pA883-A883. 1p.
Database: Academic Search Ultimate
Description
ISSN:07351097
DOI:10.1016/S0735-1097(18)31424-4